Fora long time, those diagnosed with celiac disease had no celiacdisease drugs for them. These were the types of treatments that wererecommended by physicians and others who are knowledgeable about thiscondition. It was believed for a long time that those diagnosed wouldsimply have to live with their condition and avoid certain things. Noone really understood the nature of this disorder. However, recentadvances in celiacdisease drugs have been made. This has been very important as thenumber of people with this disorder continues to rise. As per theCeliac India Organization, the prevalence of the celiac diseaseacross the globe is around 1%.
Currently,there are two general categories of celiac disease drugs. One ofthese is a type that has been available for decades. These are themore conventional forms of treatment. In addition to a gluten-freediet, these drugs involve dietary modifications. This includesremoving wheat and other foods from the diet that have been proven tobe sources of gluten. Another category of celiac disease drugs isrepresented by enzyme blockers. These are used primarily to treatthose with more advanced stages of the condition. The use of thismedication can also help to keep the weight under control and help tomaintain a lifelong gluten-free diet. The effects of obesity are alltoo well known.
Lastly,there is the gluten-free diet medication, which is the last part ofthe celiac disease drug pipeline report. This type of medicine hasbeen tested in the lab and will continue to progress through clinicaltrials. As of right now, there are no known side effects associatedwith this medication. However, any potential side effects will needto be tested in a double-blind clinical trial. Recently, in August2020, Provention Bio Inc., a biopharmaceutical company, imitatedPhase IIB Proactive study of PRV-015 (anti-IL-15) in non-responsiveceliac disease.
